Key result
A derived risk score model successfully stratified patients undergoing ventricular tachycardia ablation, with any complication rates increasing from 2.7% in the lowest risk group to 31% in the highest risk group.
Why the study?
Can a clinical risk score model predict complications and in-hospital mortality in patients undergoing ventricular tachycardia ablation?
Observational (n=25,451)
Yes
Can a clinical risk score model predict complications and in-hospital mortality in patients undergoing ventricular tachycardia ablation?
Absolute Event Rate: 31% vs 2.7%
A simple clinical risk score model can effectively stratify the risk of complications and in-hospital mortality for patients prior to undergoing ventricular tachycardia ablation.
Provides a real-world risk stratification tool for VT ablation complications; leaves open whether prospective application of.
AIMS: Outcome data on ventricular tachycardia (VT) ablation has been limited to few experienced centres. We sought to identify complication rates, predictors, and create a risk score model for predicting complications in patients from real-world data. METHODS AND RESULTS: A total of 25 451 patients undergoing VT ablation from year 2006 to 2013 were identified from the National Inpatient Sample (NIS) database. The whole cohort was randomly divided into derivation cohort to derive the model and validation cohort to validate the model. Multivariate predictors of any complication were identified using regression model. Each predictor was assigned a risk score and each patient was assigned to one of the four groups (risk score in parenthesis) based on total combined risk score: Group 0 (0), Group 1 (1-5), Group 2 (6-10), and Group 3 (>11). The rate of 'any complication' and 'in-hospital mortality' in whole cohort was 14.7% and 2.8%, respectively. The predictors of any complication include chronic kidney disease, coagulopathy, chronic liver disease, stroke (cerebrovascular accident), emergency procedure, age ≥ 65 years, coronary artery disease, peripheral vascular disease, and female gender. There was a significant increase in complication rate in a linear fashion as the risk score increased. The incidence of any complications increased from 2.7% in Group 0 to 31% in Group 3. The risk score model performed well in predicting complications associated with VT ablation. CONCLUSION: Patients with higher risk scores have significant increase in any complication and in-hospital mortality from VT ablation. The simple risk score model can help to risk stratify patients prior to VT ablation.
No takes yet. Share an insight, caveat, or question.
Gunda et al. (2018) conducted an observational in Ventricular tachycardia (n=25,451). High risk score (>11) vs. Low risk score (0) was evaluated on Any complication. A derived risk score model successfully stratified patients undergoing ventricular tachycardia ablation, with any complication rates increasing from 2.7% in the lowest risk group to 31% in the highest risk group.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: